DE69711907D1 - Mindestens eine nukleinsäure enthaltende zusammensetzungen - Google Patents

Mindestens eine nukleinsäure enthaltende zusammensetzungen

Info

Publication number
DE69711907D1
DE69711907D1 DE69711907T DE69711907T DE69711907D1 DE 69711907 D1 DE69711907 D1 DE 69711907D1 DE 69711907 T DE69711907 T DE 69711907T DE 69711907 T DE69711907 T DE 69711907T DE 69711907 D1 DE69711907 D1 DE 69711907D1
Authority
DE
Germany
Prior art keywords
nucleic acid
compositions containing
compositions
nucleic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69711907T
Other languages
English (en)
Other versions
DE69711907T2 (de
Inventor
Patrick Mahy
Didier Roux
Rene Laversanne
Joelle Amedee
Olivier Freund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Capsulis SA
Original Assignee
Capsulis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsulis SA filed Critical Capsulis SA
Application granted granted Critical
Publication of DE69711907D1 publication Critical patent/DE69711907D1/de
Publication of DE69711907T2 publication Critical patent/DE69711907T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
DE69711907T 1996-07-16 1997-07-15 Mindestens eine nukleinsäure enthaltende zusammensetzungen Expired - Fee Related DE69711907T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9608844A FR2751222B1 (fr) 1996-07-16 1996-07-16 Compositions contenant au moins un acide nucleique et leurs applications dans le domaine biomedical, en particulier en therapie genique
PCT/FR1997/001304 WO1998002144A1 (fr) 1996-07-16 1997-07-15 Compositions contenant au moins un acide nucleique

Publications (2)

Publication Number Publication Date
DE69711907D1 true DE69711907D1 (de) 2002-05-16
DE69711907T2 DE69711907T2 (de) 2002-10-31

Family

ID=9494072

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69711907T Expired - Fee Related DE69711907T2 (de) 1996-07-16 1997-07-15 Mindestens eine nukleinsäure enthaltende zusammensetzungen

Country Status (9)

Country Link
US (1) US6387396B2 (de)
EP (1) EP0935458B1 (de)
JP (1) JP2000516916A (de)
AU (1) AU722479B2 (de)
CA (1) CA2260284A1 (de)
DE (1) DE69711907T2 (de)
ES (1) ES2175439T3 (de)
FR (1) FR2751222B1 (de)
WO (1) WO1998002144A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2212305T3 (es) * 1997-06-23 2004-07-16 Alza Corporation Polinucleotidos encapsulados en liposomas, composicion y procedimiento.
FR2766706B1 (fr) * 1997-07-30 2001-05-25 Biovector Therapeutics Sa Complexes particulaires stables de charge globale neutre ou negative de structure multilamellaire composes par au moins une substance biologiquement active globalement anionique et un constituant cationique, leur preparation et utilisation
FR2766705B1 (fr) * 1997-07-30 2001-05-25 Biovector Therapeutics Complexe particulaire de charge globale neutre ou negative forme d'une vesicule cationique ou neutre et d'une substance biologiquement active anionique, leur preparation et leur utilisation
FR2769022B1 (fr) * 1997-09-29 2000-11-03 Capsulis Vecteurs d'antigenes et compositions therapeutiques contenant des antigenes
FR2790975B1 (fr) * 1999-03-16 2001-06-01 Capsulis Milieux sous forme de dispersions complexes, leur procede de preparation et leurs utilisations
FR2802422B1 (fr) * 1999-12-21 2002-08-09 Capsulis Structures mixtes resultant de l'incorporation d'une macromolecule biologique, en particulier d'adn, dans une phase structuree d'amphiphiles et vesicules obtenues a partir de ces structures
WO2001064164A2 (en) * 2000-02-28 2001-09-07 Genesegues, Inc. Nanocapsule encapsulation system and method
AU2002220522A1 (en) * 2000-12-01 2002-06-11 Novozymes A/S Encapsulation of compounds in vesicles
CA2553714A1 (en) * 2004-01-23 2005-08-04 Keio University Support accumulating in injured part in vascular channel
WO2006101201A1 (ja) * 2005-03-24 2006-09-28 National University Corporation Hokkaido University 目的物質を効率的に核内に送達可能なリポソーム
GB0605521D0 (en) * 2006-03-18 2006-04-26 Isis Innovation Adjuvant
KR101601035B1 (ko) 2013-02-28 2016-03-08 주식회사 종근당 키토산 및 액상결정 형성 물질을 포함하는 유전자 전달용 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US5169637A (en) * 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
US5723147A (en) * 1987-02-23 1998-03-03 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5286634A (en) * 1989-09-28 1994-02-15 Stadler Joan K Synergistic method for host cell transformation
DE4005152A1 (de) * 1990-02-17 1991-08-22 Guenter Prof Dr Kahl Verbesserung der transformation von pflanzenzellen
JPH07502510A (ja) * 1991-12-17 1995-03-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 嚢胞性繊維症膜貫通型コンダクタンス調節活性（ｃｆｔｒ）のための遺伝子治療
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
JPH09510433A (ja) * 1993-12-17 1997-10-21 マイクロパック インコーポレイテッド 生物学的に活性な物質を細胞に送達する方法
FR2714621B1 (fr) * 1994-01-06 1996-02-23 Centre Nat Rech Scient Procédé de préparation de liposomes sans utilisation de solvant organique.
US5672358A (en) * 1994-06-21 1997-09-30 Ascent Pharmaceuticals, Inc. Controlled release aqueous emulsion
US5627159A (en) * 1994-10-27 1997-05-06 Life Technologies, Inc. Enhancement of lipid cationic transfections in the presence of serum
US5827531A (en) * 1994-12-02 1998-10-27 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microcapsules and methods for making
AU6691496A (en) 1995-08-01 1997-02-26 Advanced Therapies, Inc. Enhanced artificial viral envelopes for cellular delivery of therapeutic substances
IL115199A (en) * 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition

Also Published As

Publication number Publication date
EP0935458B1 (de) 2002-04-10
WO1998002144A1 (fr) 1998-01-22
JP2000516916A (ja) 2000-12-19
US20020012696A1 (en) 2002-01-31
AU3698297A (en) 1998-02-09
FR2751222B1 (fr) 1998-10-09
ES2175439T3 (es) 2002-11-16
DE69711907T2 (de) 2002-10-31
FR2751222A1 (fr) 1998-01-23
EP0935458A1 (de) 1999-08-18
AU722479B2 (en) 2000-08-03
CA2260284A1 (en) 1998-01-22
US6387396B2 (en) 2002-05-14

Similar Documents

Publication Publication Date Title
DE69901396D1 (de) Zusammensetzung enthaltend beta-hydroxy-beta-methylbutyratsäuere und mindestens ein aminosäure
DE69918278D1 (de) Substituierte indolalkansäure
DE69841895D1 (de) Nukleinsäuretestverfahren
ID18063A (id) Turunan-turunan asam arilsufonilamino hidroksamat
ATE239005T1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
ID28699A (id) Turunan-turunan asam oksiiminoalkanoat
DE69635744D1 (de) Modifizierte Nukleinsäuresonden
DE69403809T2 (de) Alternative kuehlmittelzusammensetzung
FI961720A (fi) Uusi koostumus
DE69836106D1 (de) Stanolester enthaltende Zusammensetzungen
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
BR9708793A (pt) Composições ácidas redutoras de cisalhamento espessas
NO975453D0 (no) Kjemisk sammensetning
DE69711907T2 (de) Mindestens eine nukleinsäure enthaltende zusammensetzungen
DE59402189D1 (de) 2-Keto-3-methyl-4-hydroxy-valeriansäure
DE69406069T2 (de) Elektrotauchlackzusammensetzung
DE69415720T2 (de) Wasserverdünnbare Farbstoffzusammensetzungen
NO991561D0 (no) 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
ID22406A (id) Komposisi-komposisi umpan racun
BR9711811A (pt) Composi-{es insenticidas
NO961783L (no) 5-arylisoxazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
FI961520A (fi) Heribisidiset atsabisfosfonihappoyhdisteet
KR950001267U (ko) 전기핵산유출기
DE69515955T2 (de) Säurefarbstoff enthaltende Zusammensetzungen
DE69529312D1 (de) Alkoholarme Parfümzusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8339 Ceased/non-payment of the annual fee